Excessive EXO1 protein activity linked to genome instability and cancer sensitivity

Source:Science Daily

02 — Who / Subject

George-Lucian Moldovan, Alexandra Nusawardhana, Penn State College of Medicine

03 — Where / Locus

USA

04 — When / Temporality

June 2026

Verified: June 20, 2026

05 — Why / Core Summary

"Penn State researchers found that excessive EXO1 activity damages DNA, destabilizing the genome. Tumors with high EXO1 levels behave like BRCA-mutant cancers and may respond to similar targeted therapies."

Conflict Analysis

Provinformations a potential new biomarker for personalized cancer treatment, expanding the use of existing therapies to non-BRCA patients.

Post

COMPAMIR

COMPAMIR

Excessive EXO1 protein activity linked to genome instability and cancer sensitivity